(NYSE: AORT) Artivion's forecast annual revenue growth rate of 9.02% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Artivion's revenue in 2026 is $471,474,000.On average, 10 Wall Street analysts forecast AORT's revenue for 2026 to be $24,181,135,367, with the lowest AORT revenue forecast at $22,934,926,358, and the highest AORT revenue forecast at $25,295,215,017. On average, 10 Wall Street analysts forecast AORT's revenue for 2027 to be $26,844,200,158, with the lowest AORT revenue forecast at $25,070,936,400, and the highest AORT revenue forecast at $28,422,926,594.
In 2028, AORT is forecast to generate $29,878,299,791 in revenue, with the lowest revenue forecast at $27,789,583,283 and the highest revenue forecast at $31,825,623,258.